Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For HPK
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Balanced
50%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -9.26 1.04 1.14
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2.01 4.06 3.98
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.16 12.32 12.30
Cash -10.48 1.38 1.54
Capex 20.37 -1.19 -1.50
Free Cash Flow -52.57 0.17 0.36
Revenue -4.03 2.29 2.39
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.68 0.39 0.38
Operating Margin 0.75 0.36 0.36
ROA -93.03 < 0.005 0.03
ROE -93.20 < 0.005 0.06
ROIC -7.37 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of HPK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of HPK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of HPK is permitted for members.